Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: compazine attending: chief complaint: abdominal pain major surgical or invasive procedure: none history of present illness: this is a 53 y/o f with a pmhx of metastatic breast ca unresponsive to previous chemo regimens recently 1 dose of doxil (), chronic pe on lovenox, asthma, allergic rhinitis, now presenting with 5 days of l lower chest/left upper abdominal pain, accompanied with occasional nausea. she denies any pleuritic component to this l lower chest pain, without radiation to her back or neck/arm. she denies any sob, or dyspnea on exertion from her prior baseline. she has been taking her lovenox injections regularly since her discharge 1 month ago. she does state that she has had abdominal distension and describes her luq abd pain as "gurgling" in nature. does admit to constipation, with normal bm over 6 days ago. has taken miralax since monday without much improvement. no hematemesis, diarrhea. . on arrival to the ed, vs t97.1, hr145, bp94/49, rr32, satting 90%on nrb. she received 2l ns, 6mg ms iv, levaquin 500mg x1, ceftriaxone 2g iv x1. she had an us-guided paracentesis performed that removed 3l of yellow-green fluid. past medical history: 1) metastatic breast cancer: t2-no, er/pr + her-2/neu (-), diagnosed -: she was treated with cmf plus tamoxifen and local radiation. -: treated with epirubicin/taxotere after found to have adrenal met --: on arimidex, then found to have liver mets -: started on xeloda -: treated with taxol -: phase ii study of (tyrosine kinase inhibitor) -: cancer metastasized to liver and adrenals -: has received 2 treatments with gemcitabine : thoracentesis with fluid positive for malignant cells : right vats, talc pleurodesis by dr. with placement of pleur-x cath : 3rd dose of gemcitabine currently treated w/ navelbine, last dose 2 wks ago. 2) malignant pleural effusion s/p pleurex catheter placed removed 3) asthma 4) allergic rhinitis 5) gerd social history: lives with husband, 23 year-old daughter, and 6 month-old grandson. smoked. no alcohol, cocaine, or ivdu. family history: 1. breast cancer: uncle 2. lung ca: father, sister physical exam: vs: t95.5 hr135 bp 104/78 rr 28 o2sat: 96% on 4l nc gen: appears stated age, mild discomfort due to pain, able to speak in full sentences heent: anicteric sclera bilat. perrl. eomi. neck: no elevated jvp cv: tachycardic. nml s1,s2. no murmurs resp: decreased bs at bases r>l, crackles @ both bases. decreased percussion bilat. chest/abd: mild ttp over distal ribs on l chest. no ttp over abdomen. no rebound/guarding. no fluid wave. ext: no edema bilat. neuro: aaox3. pertinent results: ekg: sinus tach, 150. nml axis, nml intervals. no st or tw changes. . imaging: echo : ef >60%. pasp 41. the left atrium is normal in size. left ventricular wall thicknesses are normal. the left ventricular cavity size is normal. overall left ventricular systolic function is normal (lvef>55%). right ventricular chamber size and free wall motion are normal. the mitral valve appears structurally normal with trivial mitral regurgitation. tricuspid regurgitation is present but cannot be quantified. there is moderate pulmonary artery systolic hypertension. there is an anteriorspace which most likely represents a fat pad, though a loculated anterior pericardial effusion cannot be excluded. . ct torso c contrast : 1. chronic pulmonary embolism of the left main pulmonary artery and right lower lobe pulmonary artery with interval retraction of left main pa clot. no acute pulmonary embolism identified. 2. new moderate left pleural effusion with left basilar consolidation, probably atelectasis, but pneumonia cannot be excluded. 3. no significant change in appearance of the right hemithorax including moderate right pleural effusion, concentric pleural thickening, and right lower lobe consolidation with interstitial thickening possibly indicating lymphangitic spread of tumor. 4. no significant change in mediastinal and hilar lymphadenopathy. 5. interval in now moderate-to-severe ascites and increased omental soft tissue consistent with omental carcinomatosis. 6. no significant change in innumerable hepatic metastases. 7. no significant change in diffuse osseous metastases. 8. enlarged subcutaneous soft tissue densities of the abdominal wall may represent injection sites or less likely metastatic foci. brief hospital course: this was a 53 year-old female with a history of metastatic breast ca unresponsive to previous chemo regimens, chronic pe on lovenox, and asthma who presented with hypoxia and abdominal pain. . #hypoxia the patient had a known chronic r pleural effusion, with stable chronic pes who presented with sob and new l pleural effusion. her sob appears to be at her baseline. her new l pleural effusion likely represents a malignant effusion given lack of infectious symptoms and h/o r malignant effusion. she required only nasal cannula supplementation during her admission. . #hypotension/tachycardia likely etiology of hypotension is hypovolemia secondary to decreased po intake. she received 2l ns in the ed with mild improvement in hemodynamics. no pe was seen on ct. 3l of ascites fluid was drained in ed without evidence of sbp or other systemic infection. there may have been an element of adrenal insufficiency given metastatic involvement of r adrenal gland and prior removal. she was continued with iv hydration as needed on the floor. . #l chest/abd pain this likely represented an element of musculoskeletal pain from osteolytic lesions as seen on ct torso, with a component of hypercalcemia. she had no evidence of new/ pe burden on ct torso. she underwent paracentesis in the ed with removal of 3l to make the patient more comfortable. she was given an aggressive bowel regimen with iv hydration. she was started on a fentanyl patch with prn dilaudid. . #hypercalcemia this was thought to be due to malignancy. she was given pamidronate 90 mg iv, with some response in her calcium levels. . # hx of pe she was continued on her treatment regimen of lovenox 70mg sc bid. there was no evidence of new/ clot burden at this time. . #breast ca pt with metastatic breast ca that has not responded to tx as above. recently started on doxorubicin 1 month ago for refractory metastatic breast ca. ct torso today revealed metastatic disease with omental carcinomatosis. after speaking with her primary oncologist, it was clear that there were no further treatments for the patient. the patient and her family requested a palliative care consultation. plans were made for home hospice. she was discharged home with pain medications and home hopsice services. medications on admission: lovenox 70mg q12 zofran 8 mg po bid megestrol 40 protonix 40 percocet prn ativan prn discharge medications: 1. fentanyl 50 mcg/hr patch 72hr sig: one (1) patch 72hr transdermal q72h (every 72 hours). disp:*10 patch 72hr(s)* refills:*2* 2. dilaudid-5 1 mg/ml liquid sig: 4-10 mg po q 1-2 hr: please administer 20 mg/ml. disp:*1 vial* refills:*2* discharge disposition: home with service facility: hospice of the good discharge diagnosis: metastatic breast cancer discharge condition: stable, pain-controlled discharge instructions: please take all of your medications as prescribed. please return to the emergency room should you experience severe nausea, vomiting, chest discomfort, diarrhea or other symptoms that concern you. followup instructions: provider: , md phone: date/time: 1:00 provider: , rn phone: date/time: 1:30 md procedure: percutaneous abdominal drainage diagnoses: esophageal reflux malignant neoplasm of liver, secondary asthma, unspecified type, unspecified personal history of malignant neoplasm of breast secondary malignant neoplasm of lung secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of adrenal gland 

Answer: The patient is high likely exposed to